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Summary
AIMS OF THE STUDY: The spectrum of agents available
for procedural analgosedation (PAS) in paediatric emer-
gency departments (EDs) has increased over the last few
decades, yet the pharmacological agents most used in
our ED are ketamine and nitrous oxide (N2O). The aim of
this study was to assess which patient characteristics in
an ambulatory setting were associated with physicians se-
lecting N2O 70% or ketamine as the sedating agent in our
paediatric ED, after N2O 70% was introduced.
METHODS: Patients aged 0 to 16 years who received
PAS in a tertiary children’s hospital ED in 2007 (before
N2O 70% implementation) and 2016 (after N2O implemen-
tation) were included in this retrospective, single-centre
cohort study. Data were collected by querying the outpa-
tient ED database for N2O 70% and ketamine. Obtained
data included patient characteristics, procedure type and
sedation medication.
RESULTS: 1168 patients were included; 59.8% (699) were
male. The overall mean age was 6.3 (± 4.0) years; in
the ketamine subgroup, 4.6 (± 4.0) years and in the N2O
subgroup, 7.8 (± 3.4) years. In 2016, N2O was chosen
in 86.7% of cases involving children aged 4 to 16 years,
compared to 28.5% of cases involving children three years
and younger. The most apparent shift from ketamine to
N2O occurred in patients with displaced upper extremity
fractures, with an increase of N2O 70% from 0% in 2007
to 90.8% in 2016.
CONCLUSIONS: The use of ketamine PAS shifted to N2O
PAS, especially in children older than three years and for
the reduction of displaced upper extremity fractures.
Keywords: paediatric emergency department, nitrous ox-
ide, ketamine, procedural analgosedation
Introduction
Procedural analgosedations (PAS) in paediatric emergency
departments (EDs) are challenging. On the one hand, ap-
propriate pain control is of paramount importance to avoid
psychological trauma for a child and on the other, several
other factors must also be considered: the child’s character-
istics, the planned procedure, and the ED’s resources (man-
power, bed space) [1–4]. Although the spectrum of agents
available for PAS has increased over the last two decades,
our ED mainly uses two pharmacologic agents, ketamine
and nitrous oxide (N2O) [5–13].
Ketamine, a nonbarbiturate anaesthetic with an onset with-
in seconds when applied intravenously, is a noncompeti-
tive N-methyl-D-aspartate (NMDA) and glutamate recep-
tor antagonist with sedative, analgesic, and amnestic
properties. It is mainly used for short-term procedures that
do not require skeletal muscle relaxation. Ketamine is
metabolised via the hepatic system, with a half-life of ap-
proximately 45 minutes [7, 8]. Since the 1990s, it has be-
come one of the most often used sedatives in paediatric
EDs because it allows spontaneous respiration due to the
maintenance of laryngeal and pharyngeal reflexes and is
also associated with respiratory and cardiovascular stim-
ulation [2]. Potential serious side effects of ketamine are,
amongst others, apnoea and laryngospasms, as well as car-
diac and respiratory arrest. Therefore, both close monitor-
ing and highly trained personnel who can manage these
complications are essential. In our ED, this PAS is per-
formed exclusively by anaesthesiologists [5, 9].
Nitrous oxide (N2O), a colourless, tasteless and odourless
gas with sedative, analgesic, anxiolytic and amnestic ef-
fects, has been used in dental-care settings for decades,
but was introduced into paediatric EDs only in the 1990s,
mainly for minor, painful procedures like placing an in-
travenous line or suturing a laceration in anxious children
[5, 9, 11–13]. For procedures with a high pain score, the
analgesic power of N2O 50% combined with 50% oxygen
is insufficient, so N2O 70% was introduced into our ED a
decade ago. N2O 70% is an almost ideal agent for PAS in
children because it is sufficient for most short, painful pro-
cedures, and neither an intravenous line nor fasting is re-
quired. Furthermore, its onset is rapid and recovery takes
only three to five minutes once the gas is withdrawn [13].
Adverse events are mainly nausea, vertigo and vomiting.
Hence, a trained ED consultant performs these PAS with-
out an anaesthesiologist in our ED [13].
Ketamine and N2O 70% are routinely used for sedation
in paediatric EDs. However, studies have focused mainly
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on adverse events and sedation practices [14–16]. Our lo-
cal policy, with anaesthesiologists performing ketamine se-
dations, may not be representative of most paediatric ED
practices but, to the best of our knowledge, we are the first
to analyse the changes of PAS practice caused by the im-
plementation of N2O 70% in a paediatric ED.
The aim of this study was to assess which patient char-
acteristics were associated with physicians selecting N2O
70% or ketamine as the sedating agent in our paediatric ED
after the introduction of N2O 70%.
Material and methods
Patient population
Patients aged 0 to 16 years who received PAS in the ED of
the University Children’s Hospital Zurich in 2007 (before
N2O 70% implementation) and in 2016 (after N2O 70%
implementation) were included in this retrospective, sin-
gle-centre cohort study. The local ethics board approved
this study.
Data collection
Data was collected by querying our outpatient ED database
for N2O and ketamine. The clinical records of all patients
included were reviewed and the following data were col-
lected: demographics (age and gender), indication for PAS,
choice of N2O or ketamine, whether ketamine had to be
chosen because of the insufficiency of N2O sedation, ad-
verse events of N2O PAS, and who performed the proce-
dure (ED physician or other specialist).
Procedural analgosedation
N2O was applied through a facemask covering the patient’s
nose and mouth with a demand valve system, using the
Ventyo machine (LINDE Gas GmbH, 4651 Stadl-Paura,
Austria). No fasting period or intravenous line was neces-
sary, parents were allowed to be present during PAS, and
discharge was possible immediately following the proce-
dure.
In contrast, ketamine PAS required the child to fast and re-
ceive an intravenous line. An anaesthesiologist performed
the ketamine PAS and monitored the patient during and af-
ter the procedure until discharge. The parents were sent out
of the room as soon as the child was analgosedated, and
then the intervention was performed by either an ED physi-
cian or, in potentially more severe cases, a paediatric sur-
geon.
Statistics
Categorical data were described as frequencies, while con-
tinuous variables were described as means with standard
deviation (SD). Statistical analyses were performed with
IBM® SPSS® statistics version 24.
Results
A total of 1168 children were treated with PAS during the
study period and were included in this study, of which
59.8% (699/1,168) were boys. Overall, 53.7% of children
received N2O 70% and 46.3% ketamine, most frequently
for orthopaedic interventions (29.9%), wound suturing
(25.9%), burn debridement (15%) and removal of foreign
bodies (13.3%) as detailed in table 1.
The overall mean age was 6.3 (± 4.0) years; in the keta-
mine subgroup, the mean age was 4.6 (± 4.0) years, while
in the N2O subgroup it was 7.8 (± 3.4) years. Figure 1 il-
lustrates the variability of the PAS chosen in different age
groups in 2016. The use of N2O in the age group up to
three years was low (28.5%; 63/221), in contrast to the oth-
er age groups (4-16 years) where it was chosen in 86.7%
(561/647) of cases.
An increase in PAS with N2O and a corresponding de-
crease in ketamine use was observed from 2007 to 2016
(table 2). The most apparent shifts from ketamine to N2O
over the study period occurred in the patient group with
displaced upper extremity fractures and in patients with
lacerations (table 3). The rate of N2O for the reduction
of upper extremity fractures increased from 0% to 90.8%
(table 3). Suturing showed a less significant decrease in ke-
tamine PAS; N2O PAS increased from 0% to 61.1%, main-
ly in older children (mean age ± SD: with ketamine PAS,
3.3 ± 3.3 years compared to N2O PAS, 6.6 ± 2.9 years)
(table 4). Age and the affected localisations were decisive
factors as to which PAS was chosen for suturing, as de-
tailed in table 4. Similarly, a shift from ketamine PAS to-
ward N2O PAS occurred in burn debridement, but signif-
icant differences in mean age and amount of injured skin
appeared between the two PAS groups. Children who re-
ceived N2O had a mean age of 5.8 (± 3.2) years compared
Table 1: Characteristics of patients who received nitrous oxide 70% (N2O 70%) or ketamine
Overall
(n = 1168)
N2O 70%
(n = 627)
Ketamine
(n = 541)
Mean age, y (SD) 6.3 (4.0) 7.8 (3.4) 4.6 (4.0)
Sex, male, n (%) 699 (59.8) 363 (57.9) 336 (62.1)
Procedures:
Orthopaedic, n (%) 349 (29.9) 240 (38.3) 109 (20.1)
‒ Reduction upper extremity fracture, n 328 220 108
‒ Reduction lower extremity fracture, n 21 20 1
Wound suturing, n (%) 302 (25.9) 129 (20.6) 173 (32.0)
Burn debridement, n (%) 175 (15.0) 62 (9.9) 113 (20.9)
Removal of foreign body, n (%) 155 (13.3) 62 (9.9) 93 (17.2)
Abscess incision, n (%) 106 (9.1) 65 (10.4) 41 (7.6)
Other, n (%) 81 (6.9) 69 (11.0) 12 (2.2)
Figure 1: Procedural analgosedation in different age groups in 2016.Ketamine-ED: Intervention was performed by an ED physician; Keta-
mine-OR: Intervention was performed in the operation room by a paediatric surgeon (potentially more severe cases).
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to a mean age of 2.1 (± 2.3) years for children who re-
ceived ketamine. Children who received N2O had a mean
affected body surface area of 1.6% (± 1.2), while children
who received ketamine had a mean affected body surface
area of 3.2% (± 2.4).
Adverse events, mostly nausea, vertigo and vomiting dur-
ing and after N2O PAS, occurred at a rate of 40%, although
no serious adverse events occurred during N2O PAS and
the satisfaction rate among children and parents was over
95%. The N2O PAS regime needed to be changed to keta-
mine in 1.8% (11/627) of all children who received N2O,
either because N2O PAS was insufficient or because ad-
verse events occurred. These children were mostly boys
(81.8%) with a mean age of 7.8 ± 4.5 years. Indications for
Table 2: Age groups and indications for sedations before (2007) and after (2016) introducing nitrous oxide 70% (N2O 70%)
2007
n = 298
2016
n = 870
N2O 70%, n (%) 0 615 (70.7)
Ketamine ‒ emergency department, n (%) 232 (77.9) 168 (19.3)
Ketamine ‒ operating room*, n (%) 66 (22.1) 87 (10.0)
Age groups:
‒ 0-3 years, n (%) 119 (39.9) 221 (25.4)
‒ 4–7 years, n (%) 104 (34.9) 314 (36.1)
‒ 8–11 years, n (%) 44 (14.8) 211 (24.3)
‒ 12–16 years, n (%) 31 (10.4) 124 (14.2)
Procedures:
‒ Orthopaedic, n (%) 91 (30.5) 258 (29.7)
‒ Reduction upper extremity fracture, n 90 238
‒ Reduction lower extremity fracture, n 1 20
‒ Wound suturing, n (%) 94 (31.5) 208 (23.9)
‒ Burn debridement, n (%) 48 (16.1) 127 (14.6)
‒ Removal of foreign body, n (%) 36 (12.1) 119 (13.7)
‒ Abscess incision, n (%) 26 (8.7) 80 (9.2)
‒ Other, n (%) 3 (1.0) 78 (9.0)
* Intervention was performed by a paediatric surgeon (potentially more severe cases)
Table 3: Procedural analgosedation for reduction of upper extremity fractures and wound suturing in 2007 and 2016
2007 2016
N2O 70%* Ketamine-ED** Ketamine-OR*** N2O 70%* Ketamine-ED** Ketamine-OR***
Reduction upper extremity fracture, n (%) 0 69 (76.7) 21 (23.3) 216 (90.8) 10 (4.2) 12 (5.0)
Wound suturing, n (%) 0 82 (87.2) 12 (12.8) 127 (61.1) 67 (32.2) 14 (6.7)
* nitrous oxide 70%; ** emergency department; *** operation room: intervention was performed by a paediatric surgeon (potentially more severe cases)
Table 4: Procedural analgosedation for wound suturing in 2016; age dependency and affected localisations
Localisations Nitrous oxide Ketamine Total
Finger/Toe, n (%) 47 (64.4%) 26 (35.6%) 73
Age, years, mean (SD) 6.7 (± 2.4) 3.7 (± 2.9) 5.7 (± 3.8)
Lips, n (%) 6 (17.1%) 29 (82.9%) 35
Age, years, mean (SD) 5.3 (± 2.3) 2.2 (± 1.6) 2.7 (± 2.6)
Arm/Leg, n (%) 27 (90%) 3 (10%) 30
Age, years, mean (SD) 7.6 (± 2.4) 8.5 (± 5) 7.7 (± 3.3)
Chin, n (%) 18 (100%) 0 18
Age, years, mean (SD) 5.6 (± 2.5) 5.6 (± 2.5)
Nose/Ear 5 (29.4%) 12 (70.6%) 17
Age, years, mean (SD) 5.6 (± 1.3) 2 (± 0.6) 3.2 (± 1.9)
Cheek 8 (72.7%) 3 (27.3%) 11
Age, years, mean (SD) 4.1 (± 1.2) 2.7 (± 1.6) 3.7 (± 1.8)
Scalp 8 (88.9%) 1 (11.1%) 9
Age, years, mean (SD) 7.1 (± 1.8) 3 6.7 (± 2.5)
Eyebrow 4 (80%) 1 (20%) 5
Age, years, mean (SD) 8 (± 2) 3 7 (± 3)
Trunk 3 (75%) 1 (25%) 4
Age, years, mean (SD) 9.2 (± 1.9) 10 9.3 (± 2.1)
Genitals 1 (25%) 3 (75%) 4
Age, years, mean (SD) 6 7.7 (± 0.9) 7.3 (± 1.3)
Tongue 0 2 (100%) 2
Age, years, mean (SD) 1.5 (± 0.5) 1.5 (± 0.5)
All localisations 127 (61.1%) 81 (38.9%) 208
Age, years, mean (SD) 6.6 (± 2.9) 3.3 (± 3.3) 5.3 (± 3.5)
Original article Swiss Med Wkly. 2019;149:w20027
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the PAS in these children were, amongst others, burn de-
bridement (6.5%; 4/62), removal of foreign bodies (4.9%;
3/61), and reduction of upper extremity fractures (1.4%; 3/
218).
The cost of treatment of a displaced upper-arm fracture
with ketamine PAS were approximately twice as high as
for N2O 70% PAS (CHF 990 compared to CHF 470). Cost
analysis showed that the main factor for the higher costs
for ketamine PAS was the requirement of more medical
personnel compared to N2O PAS.
Discussion
This retrospective study analysed the change in PAS for
children before and after introducing N2O 70% in an am-
bulatory ED setting, with a shift from ketamine PAS to
N2O PAS, especially in children older than three years and
most significantly for the reduction of displaced upper ex-
tremity fractures.
Choosing the best PAS for children in a paediatric ED de-
pends on factors affecting the child, the planned procedure,
the ED physician’s experience, and the ED’s and the insti-
tution’s resources. First, N2O PAS requires a cooperative
child breathing strongly enough to open a demand valve
system. In our study, this meant that N2O PAS was only
chosen for 28.5% of children three years and younger. An
alternative to a demand valve system is a system with con-
tinuous flow, which might lower the possible age limit, but
which brings with it the danger of increasing the concen-
tration of N2O in the room air above the legally set min-
imum alveolar concentration (MAC) values for N2O [17].
Second, N2O 70% is ideal for short, painful procedures
and therefore it is mainly chosen for reduction of displaced
fractures, small burn debridement, abscess incision and re-
moval of foreign bodies, whereas ketamine is more suit-
able for longer and more painful procedures. It is notewor-
thy that in 2016, N2O 70% PAS was chosen for fracture
treatment in over 90% of cases of displaced forearm frac-
tures. Ketamine PAS was chosen when a primary osteosyn-
thesis was indicated, the child was too young for a demand
valve system, or was uncooperative about accepting a face-
mask. A less apparent shift from ketamine to N2O 70% oc-
curred in patients with lacerations. Ketamine PAS was ad-
ministered in 80.6% of lip suturing cases in 2016, because
it had been determined that local anaesthesia and anxiolyt-
ics were insufficient for this delicate repair. The vermilion
border must be precisely repaired, even though lip lacera-
tions are usually slight. However, these lacerations mostly
occurred in children too young for N2O PAS (2016 data:
mean age 2.7 ± SD 2.6), which implies that age was the ac-
tual decisive factor for ketamine PAS. Similar results were
found for burn debridement in 2016, where ketamine PAS
was chosen for the younger children (mean age 2.1 years)
and those with larger affected body surface areas (mean
3.2% ± SD 2.4). The third factor concerned the ED physi-
cian. An ED physician’s experience with PAS as well as
the planned procedure probably also influence the decision
whether to choose N2O or ketamine. This choice is deter-
mined by weighing benefits and risks in the context of the
child’s needs [18]. Fourth, the overall picture must be tak-
en into consideration. In our ED, the following factors are
considered: ED resources, crowding and the availability of
the anaesthesiology team, which performs ketamine PAS.
The fifth factor in choosing the best PAS concerns the in-
stitution’s resources. A socioeconomic analysis tends to-
wards N2O PAS because less medication and fewer med-
ical personnel are required, and there is a faster discharge
and a lower risk of complication. In contrast, for ketamine
PAS, children must be fasting and have an intravenous
line placed. Anaesthesiologists are needed to perform the
anaesthesia in our ED, and a place in the recovery ward
must be organised. As a consequence, costs for ketamine
PAS are approximately twice as high as for N2O PAS.
Based on our data, we conclude that alternatives to N2O are
needed for children younger than three years and for pro-
cedures that require longer lasting effects of analgesia in
order to improve efficacy and efficiency. For these cases,
nasal application of ketamine might be an effective alterna-
tive to the intravenous route. Another alternative would be
introducing newer pharmacologic agents like dexmedeto-
midine, which we are planning to include in our ED [19].
This study confirmed that N2O 70% PAS is safe in that no
serious adverse events occurred. A change from N2O PAS
to ketamine was documented in 1.8% of all children re-
ceiving N2O, either because N2O PAS was insufficient or
because adverse events occurred.
Limitations
Several factors limit the interpretation and generalisation
of these results. First, this was a retrospective and single-
centre study. Second, patients and families were not asked
by default about the pros and cons of the chosen PAS. Oth-
er potential limitations include the lack of data as to why a
certain PAS was chosen and whether adverse events during
ketamine PAS occurred.
Our local ED setting, which depended on the availability
of the anaesthesiology team for ketamine PAS, differs from
most ED settings.
Conclusions
The rate of ketamine PAS use shifted to N2O PAS, espe-
cially in children older than three years and in the patient
group with displaced upper extremity fractures. However,
in children younger than three years and for interventions
like wound suturing and debridement, ketamine PAS was
chosen most frequently.
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